EUVIMEDEUVIMED entdecken
Open Access

Incidence and Survival Outcomes of Gastrointestinal Stromal Tumors

Christian S Alvarez, M Blanca Piazuelo, Tania Fleitas-Kanonnikoff, Jennifer Ruhl, J Alejandro Pérez-Fidalgo, M Constanza Camargo

JAMA Network Open · 19.08.2024 · 7 (8) · e2428828

DOI: 10.1001/jamanetworkopen.2024.28828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 19.08.2024. Verfasst von Christian S Alvarez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, SEER Program. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The incidence of gastrointestinal stromal tumors (GISTs) increased after the implementation of GIST-specific histology coding in 2001, but updated data on trends and survival are lacking.

Objective

To examine the evolving epidemiology of GISTs in major organ sites. Design, Setting, and Participants This descriptive, population-based cohort study used nationally representative data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program, including the SEER-22 and SEER-17 registries. Data were from evaluated patients aged 20 years or older with GISTs diagnosed between January 1, 2000, and December 31, 2019. Analyses were last updated on October 29, 2023. Main Outcomes and Measures Organ site-specific trends in age-standardized incidence rates and annual percent changes (APCs) in rates were estimated by race and ethnicity and, when possible, by sex, age, and primary indicator. Multivariable Cox proportional hazards regression models were used to examine racial and ethnic differences in overall and GIST-specific survival by site.

Results

The SEER-22 and SEER-17 datasets contained 23 001 and 12 109 case patients with GISTs, respectively. Patients in the SEER-22 registry had a mean (SD) age of 64 (13) years and 51.3% were men. With regard to race and ethnicity, 9.7% of patients were Asian or Pacific Islander, 12.3% were Hispanic, 19.6% were non-Hispanic Black, and 57.7% were non-Hispanic White. Overall incidence rates of GISTs in the SEER-22 cohort increased substantially over time for all organ sites but the colon (APCs: esophagus, 7.3% [95% CI, 4.4% to 10.2%]; gastric, 5.1% [95% CI, 4.2% to 6.1%]; small intestine, 2.7% [95% CI, 1.8% to 3.7%]; colon, −0.2% [95% CI, −1.3% to 0.9%]; and rectum, 1.9% [95% CI, 0.1% to 3.8%]). There were similar increasing trends by age groups (<50 vs ≥50 years), sex, race and ethnicity, and primary indicator for gastric and small intestine GISTs. Increases were mainly restricted to localized stage disease. Patients in the SEER-17 cohort had a mean (SD) age of 64 (14) years and 51.9% were men. With regard to race and ethnicity, 13.3% of patients were Asian or Pacific Islander, 11.6% were Hispanic, 17.8% were non-Hispanic Black, and 56.6% were non-Hispanic White. Non-Hispanic Black individuals had higher overall mortality for esophageal (adjusted hazard ratio [HR], 6.4 [95% CI, 2.0 to 20.3]) and gastric (adjusted HR, 1.4 [95% CI, 1.2 to 1.5]) GISTs compared with non-Hispanic White individuals. Asian or Pacific Islander individuals also had higher overall mortality for esophageal GISTs (adjusted HR, 5.6 [95% CI, 1.5 to 20.2]). Results were similar for GIST-specific survival. Conclusions and Relevance In this cohort study using SEER data, the incidence of GISTs in major organ sites increased in the last 2 decades among several population groups. These findings suggest that additional studies are warranted to identify risk factors, because histologic reclassification and higher availability of endoscopy and imaging do not fully explain these unfavorable incidence trends. Prevention efforts are needed to reduce the substantial survival disparities among racial and ethnic minoritized populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal Stromal TumorsSEER ProgramHumansMaleFemaleMiddle AgedIncidenceAgedUnited StatesAdultCohort StudiesAged, 80 and overGastrointestinal Neoplasms

Autor:innen und Institutionen

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
  • Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Department of Medical Oncology, Instituto de Investigación Sanitaria (INCLIVA) Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
  • Medical Oncology Department, University Hospital of Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain.
  • Centro de Investigación Biomédica en Red Cáncer, Valencia, Spain.

Zitieren

APA

Alvarez, C. S., Piazuelo, M. B., Fleitas-Kanonnikoff, T., Ruhl, J., Pérez-Fidalgo, J. A., & Camargo, M. C. (2024). Incidence and Survival Outcomes of Gastrointestinal Stromal Tumors. JAMA Network Open, 7(8), e2428828. https://doi.org/10.1001/jamanetworkopen.2024.28828

Vancouver

Alvarez CS, Piazuelo MB, Fleitas-Kanonnikoff T, Ruhl J, Pérez-Fidalgo JA, Camargo MC. Incidence and Survival Outcomes of Gastrointestinal Stromal Tumors. JAMA Network Open. 2024;7(8):e2428828. doi:10.1001/jamanetworkopen.2024.28828

BibTeX
@article{Alvarez2024,
  author = {Alvarez, Christian S and Piazuelo, M Blanca and Fleitas-Kanonnikoff, Tania and Ruhl, Jennifer and Pérez-Fidalgo, J Alejandro and Camargo, M Constanza},
  title = {Incidence and Survival Outcomes of Gastrointestinal Stromal Tumors},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {8},
  pages = {e2428828},
  doi = {10.1001/jamanetworkopen.2024.28828}
}
Kostenlos starten →